Logo image of CODX

CO-DIAGNOSTICS INC (CODX) Stock Fundamental Analysis

NASDAQ:CODX - Nasdaq - US1897631057 - Common Stock - Currency: USD

0.28  0 (-1.44%)

After market: 0.28 0 (0%)

Fundamental Rating

4

CODX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. CODX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, CODX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CODX has reported negative net income.
CODX had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CODX reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CODX reported negative operating cash flow in multiple years.
CODX Yearly Net Income VS EBIT VS OCF VS FCFCODX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -65.02%, CODX is doing worse than 71.66% of the companies in the same industry.
With a Return On Equity value of -74.83%, CODX perfoms like the industry average, outperforming 40.64% of the companies in the same industry.
Industry RankSector Rank
ROA -65.02%
ROE -74.83%
ROIC N/A
ROA(3y)-35.82%
ROA(5y)-4.97%
ROE(3y)-40.94%
ROE(5y)-6.37%
ROIC(3y)N/A
ROIC(5y)N/A
CODX Yearly ROA, ROE, ROICCODX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600

1.3 Margins

CODX has a better Gross Margin (77.52%) than 90.91% of its industry peers.
In the last couple of years the Gross Margin of CODX has grown nicely.
CODX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.47%
GM growth 5Y9.36%
CODX Yearly Profit, Operating, Gross MarginsCODX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K

More info and screens

6

2. Health

2.1 Basic Checks

CODX does not have a ROIC to compare to the WACC, probably because it is not profitable.
CODX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CODX has more shares outstanding
CODX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CODX Yearly Shares OutstandingCODX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CODX Yearly Total Debt VS Total AssetsCODX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

CODX has an Altman-Z score of -2.07. This is a bad value and indicates that CODX is not financially healthy and even has some risk of bankruptcy.
CODX has a worse Altman-Z score (-2.07) than 64.71% of its industry peers.
There is no outstanding debt for CODX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.07
ROIC/WACCN/A
WACC9.04%
CODX Yearly LT Debt VS Equity VS FCFCODX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

CODX has a Current Ratio of 4.43. This indicates that CODX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.43, CODX is in the better half of the industry, outperforming 68.45% of the companies in the same industry.
CODX has a Quick Ratio of 4.23. This indicates that CODX is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 4.23, CODX is doing good in the industry, outperforming 74.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.43
Quick Ratio 4.23
CODX Yearly Current Assets VS Current LiabilitesCODX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

CODX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.70%, which is quite good.
The Revenue for CODX has decreased by -47.67% in the past year. This is quite bad
The Revenue has been growing by 79.52% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)19.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.58%
Revenue 1Y (TTM)-47.67%
Revenue growth 3Y-65.8%
Revenue growth 5Y79.52%
Sales Q2Q%-89.25%

3.2 Future

CODX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.61% yearly.
CODX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 171.12% yearly.
EPS Next Y3.42%
EPS Next 2Y27.31%
EPS Next 3Y19.61%
EPS Next 5YN/A
Revenue Next Year-88.53%
Revenue Next 2Y-59.63%
Revenue Next 3Y111.18%
Revenue Next 5Y171.12%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CODX Yearly Revenue VS EstimatesCODX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
CODX Yearly EPS VS EstimatesCODX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CODX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CODX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CODX Price Earnings VS Forward Price EarningsCODX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CODX Per share dataCODX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as CODX's earnings are expected to grow with 19.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.31%
EPS Next 3Y19.61%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CODX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CO-DIAGNOSTICS INC

NASDAQ:CODX (7/25/2025, 8:00:00 PM)

After market: 0.28 0 (0%)

0.28

0 (-1.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-07 2025-08-07
Inst Owners17.44%
Inst Owner Change0%
Ins Owners9%
Ins Owner Change5.49%
Market Cap9.44M
Analysts80
Price Target5.61 (1903.57%)
Short Float %0.92%
Short Ratio0.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.45%
Min EPS beat(2)-3.81%
Max EPS beat(2)28.7%
EPS beat(4)3
Avg EPS beat(4)22.36%
Min EPS beat(4)-3.81%
Max EPS beat(4)59.63%
EPS beat(8)4
Avg EPS beat(8)-11.83%
EPS beat(12)6
Avg EPS beat(12)-49.97%
EPS beat(16)10
Avg EPS beat(16)-17.23%
Revenue beat(2)0
Avg Revenue beat(2)-73.95%
Min Revenue beat(2)-86.85%
Max Revenue beat(2)-61.05%
Revenue beat(4)2
Avg Revenue beat(4)128.59%
Min Revenue beat(4)-86.85%
Max Revenue beat(4)594.64%
Revenue beat(8)3
Avg Revenue beat(8)183.6%
Revenue beat(12)3
Avg Revenue beat(12)102.82%
Revenue beat(16)6
Avg Revenue beat(16)80.32%
PT rev (1m)0%
PT rev (3m)450%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-87.88%
EPS NY rev (1m)0%
EPS NY rev (3m)-17.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-60%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-68.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.7
P/FCF N/A
P/OCF N/A
P/B 0.2
P/tB 0.43
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.87
OCFYN/A
SpS0.1
BVpS1.42
TBVpS0.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -65.02%
ROE -74.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.52%
FCFM N/A
ROA(3y)-35.82%
ROA(5y)-4.97%
ROE(3y)-40.94%
ROE(5y)-6.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.47%
GM growth 5Y9.36%
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33%
Cap/Sales 12.52%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.43
Quick Ratio 4.23
Altman-Z -2.07
F-Score3
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)92.34%
Cap/Depr(5y)204.81%
Cap/Sales(3y)14.45%
Cap/Sales(5y)9.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.58%
EPS Next Y3.42%
EPS Next 2Y27.31%
EPS Next 3Y19.61%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.67%
Revenue growth 3Y-65.8%
Revenue growth 5Y79.52%
Sales Q2Q%-89.25%
Revenue Next Year-88.53%
Revenue Next 2Y-59.63%
Revenue Next 3Y111.18%
Revenue Next 5Y171.12%
EBIT growth 1Y10.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-275.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-336.35%
OCF growth 3YN/A
OCF growth 5YN/A